GlassScriptPhysician profile
Nicole M Safer
NPI 1275180457
$6,061.76
in general payments reported to CMS, 2019-2025
46 companies · $1,396 in 2025
The $1,396 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $877 · 2023: $1,937 · 2024: $1,852 · 2025: $1,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,184.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $1,936.17 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Astrazeneca Pharmaceuticals LP | $486.75 | 2023-2025 | Lynparza, Imfinzi |
| Novartis Pharmaceuticals Corporation | $294.82 | 2022-2025 | |
| Tris Pharma INC | $291.80 | 2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Stryker Corporation | $280.00 | 2022-2024 | Spy-Phi System, Molli |
| Merck Sharp & Dohme LLC | $268.69 | 2023-2025 | Keytruda, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $181.57 | 2022-2024 | |
| Collegium Pharmaceutical, INC. | $176.08 | 2025 | Jornay Pm |
| Janssen Biotech, INC. | $165.18 | 2022-2025 | Rybrevant, Darzalex, Tecvayli |
| Takeda Pharmaceuticals U.S.A., INC. | $161.78 | 2022-2024 | Fruzaqla, Ninlaro, Alunbrig |
| Davol INC. | $138.74 | 2022 | |
| Progenics Pharmaceuticals, INC. | $132.13 | 2022-2024 | Pylarify |
| Corium, LLC | $118.63 | 2025 | Azstarys |
| Regeneron Healthcare Solutions, INC. | $117.51 | 2023-2025 | Libtayo |
| Endomagnetics LTD | $113.98 | 2023 | Magseed, Magtrace |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $111.60 | 2024 | Localizer |
| Medtronic, INC. | $95.35 | 2023 | Aquamantys(Tm) |
| Puma Biotechnology, INC. | $93.08 | 2023-2024 | |
| Daiichi Sankyo INC. | $76.62 | 2023-2024 | Enhertu |
| Sun Pharmaceutical Industries INC. | $60.64 | 2022-2023 | Odomzo, Yonsa |
| Incyte Corporation | $49.46 | 2024-2025 | Jakafi, Niktimvo |
| Sobi, INC | $45.88 | 2023-2024 | |
| Bard Peripheral Vascular, INC. | $45.66 | 2023-2025 | Ultracor Twirl |
| Supernus Pharmaceuticals, INC. | $44.71 | 2025 | Qelbree |
| Seagen INC. | $43.28 | 2023 | Padcev, Tukysa |
| Eisai INC. | $42.82 | 2024 | |
| Bioprotect Medical, INC. | $41.11 | 2025 | Bioprotect Balloon Implant System |
| Tersera Therapeutics LLC | $34.20 | 2024 | Zoladex |
| Genentech USA, INC. | $31.33 | 2023 | |
| Aveo Pharmaceuticals, INC. | $30.26 | 2022-2025 | |
| Springworks Therapeutics, INC. | $30.07 | 2025 | Ogsiveo |
| Sumitomo Pharma America, INC. | $28.95 | 2024 | Orgovyx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.87 | 2024 | |
| Hologic Sales and Service, LLC | $25.79 | 2025 | Localizer |
| Rigel Pharmaceuticals, INC. | $24.83 | 2024 | Tavalisse, Rezlidhia |
| Abbvie INC. | $24.10 | 2024 | |
| Adc Therapeutics America, INC. | $23.71 | 2024 | |
| Baxter Healthcare | $22.57 | 2024 | Perclot |
| Vertical Pharmaceuticals, LLC | $22.16 | 2025 | Relexxii |
| Iovance Biotherapeutics, INC. | $21.44 | 2025 | Amtagvi |
| Ipsen Biopharmaceuticals, INC | $19.44 | 2024 | Onivyde |
| Novocure INC. | $17.94 | 2024 | Optune |
| Coherus Oncology, INC. | $17.58 | 2024 | |
| Glaxosmithkline, LLC. | $16.87 | 2025 | Ojjaara |
| Digestive Care, INC. | $16.14 | 2024 | Pertzye |
| Tempus Ai, INC | $13.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Safer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.